AIMZ Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.54M Sell
13,954
-174
-1% -$40.6K 0.97% 29
2026
Q1
$3.45M Sell
14,128
-159
-1% -$37K 1.07% 30
2025
Q4
$2.96M Sell
14,287
-148
-1% -$29.3K 0.85% 37
2025
Q3
$2.68M Sell
14,435
-96
-0.7% -$16.4K 0.84% 38
2025
Q2
$2.22M Sell
14,531
-32
-0.2% -$4.92K 0.74% 46
2025
Q1
$2.42M Buy
14,563
+498
+4% +$77.9K 0.84% 39
2024
Q4
$2.03M Sell
14,065
-99
-0.7% -$15.3K 0.71% 44
2024
Q3
$2.3M Buy
14,164
+512
+4% +$81.6K 0.78% 41
2024
Q2
$2M Sell
13,652
-398
-3% -$59.2K 0.72% 44
2024
Q1
$2.22M Sell
14,050
-499
-3% -$79.4K 0.83% 40
2023
Q4
$2.28M Sell
14,549
-99
-0.7% -$15.2K 0.92% 38
2023
Q3
$2.28M Sell
14,648
-98
-0.7% -$16.2K 1.01% 36
2023
Q2
$2.44M Sell
14,746
-13
-0.1% -$2.1K 1.05% 34
2023
Q1
$2.29M Sell
14,759
-406
-3% -$65.6K 1.02% 38
2022
Q4
$2.68M Sell
15,165
-203
-1% -$35.1K 1.26% 30
2022
Q3
$2.51M Sell
15,368
-124
-0.8% -$21K 1.27% 27
2022
Q2
$2.75M Sell
15,492
-142
-0.9% -$25.3K 1.32% 28
2022
Q1
$2.77M Sell
15,634
-783
-5% -$133K 1.14% 31
2021
Q4
$2.81M Buy
16,417
+501
+3% +$82K 1.09% 33
2021
Q3
$2.57M Buy
15,916
+201
+1% +$34.3K 1.16% 31
2021
Q2
$2.59M Sell
15,715
-14
-0.1% -$2.32K 1.16% 32
2021
Q1
$2.58M Buy
15,729
+91
+0.6% +$14.7K 1.27% 31
2020
Q4
$2.46M Buy
15,638
+1
+0% +$148 1.29% 29
2020
Q3
$2.33M Sell
15,637
-59
-0.4% -$8.73K 1.39% 27
2020
Q2
$2.21M Buy
15,696
+1
+0% +$146 1.43% 27
2020
Q1
$2.06M Sell
15,695
-349
-2% -$49.5K 1.6% 23
2019
Q4
$2.34M Sell
16,044
-199
-1% -$27K 1.51% 23
2019
Q3
$2.1M Sell
16,243
-49
-0.3% -$6.46K 1.45% 27
2019
Q2
$2.27M Buy
16,292
+1
+0% +$138 1.56% 24
2019
Q1
$2.28M Sell
16,291
-99
-0.6% -$13.3K 1.56% 20
2018
Q4
$2.12M Sell
16,390
-1,498
-8% -$209K 1.63% 21
2018
Q3
$2.47M Sell
17,888
-184
-1% -$24.5K 1.59% 20
2018
Q2
$2.19M Sell
18,072
-99
-0.5% -$12.4K 1.55% 24
2018
Q1
$2.33M Buy
18,171
+1
+0% +$135 1.69% 18
2017
Q4
$2.54M Sell
18,170
-63
-0.3% -$8.78K 1.91% 15
2017
Q3
$2.37M Buy
18,233
+1
+0% +$133 1.94% 16
2017
Q2
$2.41M Sell
18,232
-508
-3% -$64.8K 2.03% 16
2017
Q1
$2.33M Sell
18,740
-24
-0.1% -$2.87K 1.97% 14
2016
Q4
$2.16M Sell
18,764
-99
-0.5% -$11.4K 1.93% 15
2016
Q3
$2.23M Sell
18,863
-194
-1% -$23.5K 1.99% 16
2016
Q2
$2.31M Sell
19,057
-20,313
-52% -$2.31M 2.12% 12
2016
Q1
$4.11M Buy
39,370
+19,554
+99% +$2.02M 1.81% 18
2015
Q4
$2.04M Buy
19,816
+1
+0% +$101 1.86% 17
2015
Q3
$1.85M Buy
19,815
+161
+0.8% +$15.6K 1.7% 20
2015
Q2
$1.92M Buy
19,654
+1
+0% +$100 1.66% 21
2015
Q1
$1.98M Sell
19,653
-149
-0.8% -$15.2K 1.69% 20
2014
Q4
$2.07M Buy
+19,802
New +$2.09M 1.85% 19

Other funds holding JNJ

AIMZ Investment Advisors's JNJ Position: Q2 2026 in Review

AIMZ Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q2 2026, selling an estimated $40.6K and leaving 13,954 shares worth $3.54M. The position accounts for 0.97% of the portfolio, ranked #29.

AIMZ Investment Advisors first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $4.11M in Q1 2016. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • AIMZ Investment Advisors held 13,954 shares of Johnson & Johnson worth $3.54M as of Q2 2026.
  • AIMZ Investment Advisors sold 174 Johnson & Johnson shares in Q2 2026, an estimated $40.6K.
  • Johnson & Johnson made up 0.97% of AIMZ Investment Advisors's portfolio in Q2 2026, its #29 holding.
  • AIMZ Investment Advisors first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
  • AIMZ Investment Advisors's Johnson & Johnson position peaked at $4.11M in Q1 2016.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on AIMZ Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.